Clinical Trials Logo

Haemoptysis clinical trials

View clinical trials related to Haemoptysis.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT02913365 Recruiting - Lung Cancer Clinical Trials

Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis

Start date: October 2012
Phase: N/A
Study type: Observational

The study consist of a retrospective analysis of the etiologies, investigations and outcomes of patients presenting between 2005 to 2010 with hemoptysis in a North-American Tertiary center.

NCT ID: NCT02878447 Recruiting - Haemoptysis Clinical Trials

The Utility of Radiotherapy in the Management of Haemoptysis Secondary to Aspergillomata and Structural Lung Diseases

Start date: June 2016
Phase: N/A
Study type: Interventional

The sequelae of tuberculosis are still the commonest causes of haemoptysis in the developing world, where life-threatening haemoptysis remains a common and not infrequently fatal medical emergency. Haemoptysis can be life-threatening either as a result of compromised gas exchange or because of circulatory collapse secondary to acute blood loss. Haemodynamic and ventilatory support, followed by bronchial artery embolisation (BAE) as a bridge to potentially curative treatment such as lung resection, remains the standard of care. Often patients do not qualify for surgical intervention and BAE is, at best, a temporary solution. External beam radiotherapy (EBRT) may be an alternative, curative intervention in the management of haemoptysis in patients with no alternative options. There is a paucity of studies reporting the use of EBRT in patients without malignancy and with regards to specific doses of EBRT. This pilot study aims to explore the potential of varying doses of EBRT in the management of massive haemoptysis.